Veracyte (VCYT)

Veracyte (VCYT) Stock Price & Analysis


VCYT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$14.92 - $32.40
Previous Close$22.6
Average Volume (3M)580.29K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$191.14M
Total Debt (Recent Filing)$14.86M
Price to Earnings (P/E)-56.0
Oct 31, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding72,750,543
10 Day Avg. Volume556,869
30 Day Avg. Volume580,293
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)8.08
Price to Sales (P/S)18.20
Price to Cash Flow (P/CF)-52.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside40.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Veracyte’s price range in the past 12 months?
Veracyte lowest stock price was $14.92 and its highest was $32.40 in the past 12 months.
    What is Veracyte’s market cap?
    Currently, no data Available
    When is Veracyte’s upcoming earnings report date?
    Veracyte’s upcoming earnings report date is Oct 31, 2023 which is in 38 days.
      How were Veracyte’s earnings last quarter?
      Veracyte released its earnings results on Aug 08, 2023. The company reported -$0.12 earnings per share for the quarter, beating the consensus estimate of -$0.152 by $0.032.
        Is Veracyte overvalued?
        According to Wall Street analysts Veracyte’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Veracyte pay dividends?
          Veracyte does not currently pay dividends.
          What is Veracyte’s EPS estimate?
          Veracyte’s EPS estimate is -$0.15.
            How many shares outstanding does Veracyte have?
            Veracyte has 72,750,540 shares outstanding.
              What happened to Veracyte’s price movement after its last earnings report?
              Veracyte reported an EPS of -$0.12 in its last earnings report, beating expectations of -$0.152. Following the earnings report the stock price went up 7.04%.
                Which hedge fund is a major shareholder of Veracyte?
                Among the largest hedge funds holding Veracyte’s share is ARK Investment Management LLC. It holds Veracyte’s shares valued at 199M.


                  Veracyte Stock Smart Score

                  The Veracyte stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.


                  Top 5 ETFs holding VCYT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold VCYT. The ETFs are listed according to market value of VCYT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Thermo Fisher

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis